Abstract
The concept of the design of latently active drugs (or prodrugs), that is chemicals which are not themselves active but which require conversion to their active form has been well established for many years and has been used with success in many areas of therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Seligman AM, Nachlas MM, Manheimer LHI, Friedman OM, Wolf G. 1949. Ann. Surg. 130 333.
Ishidate M, Sakurai T, Yoshida T, Sato H, Matui E. 1953. GANN 44, 342.
Ross WCJ. 1962. Biological Alkylating Agents, London. Butterworth Press.
Connors TA. 1976. in Progress in Drug Metabolism, eds Bridges JW, Chasseaud LF. Wiley, New York, pp41–75.
Cox PJ, Farmer PB. 1977. Cancer Treatment Reviews, 4, 47 and 119.
Connors TA, Cox PJ, Farmer PU, Foster AB, Jarman M. 1974. Biochem. Pharmacol. 23, 115.
Connors TA, Whisson ME. 1966. Nature 210, 866.
Young CW, Yagoda A, Bittar ES, Smith SW, Grabstald H, Whitmore W. 1976. Cancer 38, 1887.
Stanners CP, Lam T, Chamberlain JW, Stewart SS, Price GB. 1981. Cell 27, 211.
Cater DB. 1964. Tumori 50. 435.
Lin AJ, Cosby LA, Shansky CW, Sartorelli AC. 1972. J. Med. Chem. 15, 1247.
Moore HW, Czerniak R. 1981. Med Res. Rev. 1, 249.
Goldacre RJ, Sylven B. 1962. Brit. J. Cancer 16, 306.
Goldacre RJ, Whisson ME. 1966. Brit.J.Cancer, 20, 801.
Chapman JD, Franko AJ, Sharplin J. 1981. Brit. J. Cancer, 43, 546.
Franko AJ, Chapman JD. 1982. Brit. J. Cancer, 45, 694.
Farber W, Toch R, Sears EM, Pinkel D. 1960. Acta Un. int. Cancr, 16 611.
Carl PL, Chakravarty PK, Katzenellenbogen JA, Weber MJ. 1980. Pro. Natl. Acad. Sci. 77. 2224.
Slater TF, White W. Personal Communication.
Fiala S, Fiala ES. 1973. J. Natl. Cancer Inst., 51, 151.
Rosalki SB. 1975. Adv. Clin. Chem., 17, 53.
Peters TJ, Seymour CA, Wells G, Fakunle F, Neale G. 1977. Br. Med. J., i, 1576.
Manson MM, Legg RF, Watson JV, Green JA, Neal GE. 1981. Carcinogenesis 2, 661.
Politzer P, Trefonas P. 1980. in Carcinogenesis. Fundamental mechanisms and environmental effects. eds. Pullman B, Tso POP, Gelboin H. Dordrecht, Boston, London. D Reidel publishing company, pp67–79.
Kuochan SM, Schubert RM. 1974. Science 185, 791.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, The Hague, Boston, London
About this chapter
Cite this chapter
Connors, T.A. (1983). Alkylating Prodrugs in Cancer Chemotherapy. In: Reinhoudt, D.N., Connors, T.A., Pinedo, H.M., van de Poll, K.W. (eds) Structure-Activity Relationships of Anti-Tumour Agents. Developments in Pharmacology, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6798-4_4
Download citation
DOI: https://doi.org/10.1007/978-94-009-6798-4_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-6800-4
Online ISBN: 978-94-009-6798-4
eBook Packages: Springer Book Archive